Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)
Clinical trial NCT01125774 · COMPLETED
Trial details
- NCT number
- NCT01125774
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-04-08
- Enrollment
- 4548
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.